ChemImage Selected for a Small Business Innovation Research Phase II Award by the U.S. NVESD
ChemImage Corporation will receive support through a U.S. Army Small Business Innovation Research (SBIR) Phase II award to continue research and development of NightGuard, a standoff hyperspectral imaging sensor.
Managed by the Night Vision and Electronic Sensors Directorate (NVESD), the 18-month contract will enable the company to build on the successes achieved in Phase I, while plotting a course for commercialization. When development is complete, NightGuard will provide soldiers with the ability to detect potential threat areas in day and nighttime situations at standoff distances.
“We’re extremely pleased to have the continued support of the NVESD,” said Patrick Treado, Ph.D., Founder & Chief Technology Officer at ChemImage. “Important federal programs like the SBIR enable us to keep making advancements in our technology which benefit end-users.”
In May of this year, ChemImage received the U.S. Army SBIR 2011 Achievement Award, recognizing the company’s exceptional SBIR Phase II efforts for the real-time chemometrics and sensor fusion software powering NightGuard.
Learn more about ChemImage’s threat detection capabilities.
About ChemImage Corporation
ChemImage Corporation is a Pittsburgh based company committed to making the world healthier and safer through dramatic advancements in chemical imaging technology. The company combines proprietary, state-of-the-art imaging sensors, algorithms and analytical software to solve the world's most challenging health and safety issues.
ChemImage seeks to provide an Awareness of Things™ (AoT™) to a global audience, using the company's innovation platforms to provide people with unprecedented levels of vision, information and situational knowledge about their surroundings in their everyday lives. To accomplish this goal, the firm develops technologies for chemical and biological applications across many global industries; including life sciences, bio-medical, security, threat detection, anatomic pathology, forensics and diagnostics.
For more information, contact ChemImage.